If you made any changes in Pure these will be visible here soon.

Personal profile


Reader in Synthetic Biology and Quantitative Genomics, Division of Evolution and Genomic Sciences, Faculty of Biology, Medicine and Health at Manchester University. Principle Investigator at the Manchester Institute of Biotechnology.  Philip is also Business Engagement Lead for the Division of Evolution and Genomic Sciences, Postgraduate Research Tutor and Biomed Sciences Academic Tutor and Academic Advisor. 


August 2007 to Present.  Reader in Synthetic Biology and Quantitative Genomics, Faculty of Biology, Medicine and Health, Manchester University, and Principle Investigator at the Manchester Institute of Biotechnology.

2018 to present. Honorary Professor, Department of  Bioengineering, University California, Berkeley, CA, USA.

2013 to 2017. Honorary Professor, Department of Biomedical Engineering, University of Irvine, California,  USA.

2006 to 2007. Visiting Professor of Applied Molecular Biology and Biochemistry, Institut für Spektrochemie und Angewandte Spektroskopie, Dortmund Institute of Technology, Germany. 

June 2004 to July 2007 Senior Lecturer in Genomics and Principal Investigator. Centre for Integrated Genomic Medical Research, & Manchester Interdisciplinary Biocentre, University of Manchester.

2002 to 2004. Senior Lecturer in Genomics. Centre for Integrated Genomic Medical Research, Medical School, University of Manchester.  

1998 to 2002.  Head of Gene Arrays and Technologies. Functional Genomics Unit, Divisions of Oncology and Infectious Diseases. Children’s Hospital, University of Zürich, Switzerland. 

1997 to 1998. Post-doctoral Fellow. .Department of Biochemistry, University of Oxford.  

1995 to 1997. Post-doctoral Fellow. The human gene mapping project, The Wellcome Trust Centre for Human Genetics, University of Oxford.

1991 to 1995. Senior Scientist, Departments of Oncology and Haematology, Department of Clinical Chemistry, Children's Hospital, Birmingham. 

Research interests

Philip Day is Reader in Quantitative Analytical Genomics at Manchester University, Director of the Quantitative Molecular Medicine Group and Principle Investigator at the Manchester Institute of Biotechnology, and a member of the Centre for Epidemiology and CIGMR, at the Medical Faculty. He currently is developing synthetic biology and chemical biology approaches to directed evolution of novel proteins and aptamers for biomedical applications. These are used in combination with expertise for building integrated pathogenesis models of CML. Other closely related studies concern the enhanced uptake of anti-cancer drugs through membrane associated transporters, and Philip maintains an academic interest in the biological significance of heterogeneity. 


PGR Tutor

Biomedical Sciences Tutor

Module co-ordinator MRes Translational Medicine

Memberships of committees and professional bodies

Chartered Scientist, 2016

Chartered Chemist, 2016

Fellow of the Royal Society of Chemistry, 2004

Fellow of the Royal Society of Biology, 2008

Senior Management Team, EGS

Business Engagement Champion, FMHS

Methodological knowledge


molecular biology

Assay development

sample preparation and handling

Single cell analysis, homogeneous sample handling

Aptamer development

Systems biology/medicine

Chemical biology

Synthetic biology


Chartered Scientist, 2016

Chartered Chemist, 2016

Fellow of the Society of Biology, 2008

Fellow of the Royal Society of Chemistry, 2004

PhD, Wolfson Research Laboratories, Faculty of Sciences, Univ of Birmingham

MPhil, Wolfson Resarch Laboratories, Faculty of Medicine, Univ of Birmingham 

BSc (Hons) Biological Sciences, University of Lancaster.

Supervision information




Analysis of microbial properties using flow cytometry

Author: Jindal, Srijan, 5 Jun 2020

Supervisor: Day, P. (Supervisor)

UoM administered thesis: Phd

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

External positions

Honorary Professor, UC Berkeley

1 Apr 2019 → …

Visiting Professor, UCI, Biomedical Engineering


Areas of expertise

  • QD Chemistry
  • RZ Other systems of medicine
  • TP Chemical technology

Research Beacons, Institutes and Platforms

  • Advanced materials
  • Cancer
  • Biotechnology
  • Digital Futures
  • Dementia@Manchester
  • Manchester Precision Medicine Institute
  • Christabel Pankhurst Institute
  • Manchester Institute of Biotechnology


Dive into the research topics where Philip Day is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles